Humacyte, Inc. (HUMA)
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.
Nkarta, Inc. (NKTX)
Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment.
Pulse Biosciences, Inc. (PLSE)
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company.
Praxis Precision Medicines, Inc. (PRAX)
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance.